Long-Term Sustained Response to Fostamatinib in 2 Patients With Chronic Refractory ITP
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Long-Term Sustained Response to Fostamatinib in Two Patients With Chronic Refractory Immune Thrombocytopenia (ITP)
Br. J. Haematol 2020 Jan 03;[EPub Ahead of Print], EJ Lee, M Izak, JB BusselFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.